{
    "clinical_study": {
        "@rank": "25046", 
        "brief_summary": {
            "textblock": "The purpose of this study  is to help determine whether cystatin C is a more sensitive\n      laboratory measurement for renal function in cirrhotic patients."
        }, 
        "brief_title": "Assessment of Renal Function in Cirrhotic Patients", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Liver Failure", 
            "Renal Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Renal Insufficiency", 
                "Liver Failure"
            ]
        }, 
        "detailed_description": {
            "textblock": "Serum cystatin C, creatinine clearance based calculations, and 125I-Iothalamate clearance\n      (Glofil) will be obtained in 220 patients with cirrhosis. Utilizing this information, the\n      correlation between cystatin C and 125I-Iothalamate clearance will be obtained. In addition,\n      the current serum creatinine based calculations and true creatinine clearance will also be\n      correlated with 125I-Iothalamate clearance. The results of this study should help to\n      determine whether serum cystatin C is a more sensitive laboratory measurement of renal\n      function in patients with cirrhosis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  over 18 undergoing evaluation for a liver transplant\n\n        Exclusion Criteria:\n\n          -  known allergy or sensitivity to 125I-Iothalamate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients from Baylor All Saints Medical Center and Baylor University Medical Center who\n        have cirrhosis and a stable urine creatinine"
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01895114", 
            "org_study_id": "010-263"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Renal function", 
            "cirrhotic patients", 
            "transplant evaluation"
        ], 
        "lastchanged_date": "March 3, 2014", 
        "location": {
            "contact": {
                "email": "Erin.Fassett@baylorhealthe.du", 
                "last_name": "Erin Fassett, RN,MSN,MBA", 
                "phone": "214-820-7755"
            }, 
            "contact_backup": {
                "email": "Michelle.Acker@baylorhealth.edu", 
                "last_name": "Michelle Acker, RN", 
                "phone": "214-820-6624"
            }, 
            "facility": {
                "address": {
                    "city": "Fort Worth", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "76104"
                }, 
                "name": "Baylor All Saint's Medical Center in Fort Worth"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Assessment of Renal Function in Cirrhotic Patients -A Comparison of Cystatin C and Creatinine Based Calculations to 125I-iothalamate", 
        "overall_contact": {
            "email": "Erin.Fassett@baylorhealth.edu", 
            "last_name": "Erin Fassett, RN", 
            "phone": "817-922-7667"
        }, 
        "overall_official": {
            "affiliation": "Baylor All Saints", 
            "last_name": "Bernard Fischbach, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Creatinine based blood and urine laboratory tests as a measure of renal function in patients with chirrosis of the liver.", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01895114"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Baylor Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Baylor Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}